
08/11/2025
This is a new drug class for a new population. Headache doctors have been waiting for years for this approval and I suspect the other CGRP medications will follow for our pediatric patients!
FDA Approves Fremanezumab as First Anti-CGRP Preventive Therapy for Pediatric Episodic Migraine!!! đź’ś
This milestone offers new hope for children and families navigating life with migraine and expands prevention options for pediatric patients.
Read more: https://www.neurologylive.com/view/fda-approves-fremanezumab-first-anti-cgrp-preventive-therapy-pediatric-episodic-migraine
📢 Join us in sharing this news with the migraine community.